About.

Lenire is a bimodal neuromodulation tool which functions by providing mild electrical pulses to the tongue, via an intra-oral element called the 'Tonguetip ®', incorporated with acoustic stimulation through headphones to drive long-lasting changes in the mind to treat ringing in the ears.

Established in 2010 by Dr. Ross 'Neill, CEO, Neuromod Instruments is a medical technology business that specialises in the design and growth of neuromodulation modern technologies to deal with the scientific requirements of underserved person populaces that live with persistent and incapacitating problems.

Considering that the previous round of moneying raised in October 2020, the business has actually made progress commercialising Lenire, broadening the gadget's schedule throughout Europe, Bookmarks developing an entirely possessed US subsidiary, Neuromod United States Inc, and securing US market approval from the FDA.

The most up to date financing - which more than increases the cash the NUI Maynooth spin-out has actually raised since it was started in 2010 - is split evenly in between venture financial obligation funding from the European Financial investment Financial institution and brand-new equity investment.